Hexylent Tablet contains Trihexyphenidyl 2mg, an anticholinergic agent primarily used in the management of Parkinson’s disease and drug-induced extrapyramidal symptoms. Trihexyphenidyl acts by blocking central cholinergic receptors, thereby restoring the balance between dopamine and acetylcholine in the central nervous system. This mechanism helps alleviate symptoms such as tremors, rigidity, bradykinesia, and muscle stiffness associated with Parkinsonism. Hexylent is also effective in reducing extrapyramidal side effects caused by neuroleptic medications, including dystonia and akathisia. The recommended dosage varies depending on the patient’s condition and response, typically starting with a low dose to minimize side effects and gradually titrated as needed. Common adverse effects include dry mouth, blurred vision, constipation, urinary retention, and dizziness, which are generally dose-dependent. Caution is advised in patients with glaucoma, prostatic hypertrophy, or gastrointestinal obstruction. Hexylent should be used under medical supervision, with regular monitoring for therapeutic efficacy and potential side effects. It is contraindicated in patients with hypersensitivity to Trihexyphenidyl or other anticholinergic agents. Overall, Hexylent Tablet offers an effective therapeutic option for managing Parkinsonian symptoms and extrapyramidal disorders.